Time without transfusion reliance: a novel patient-centric metric for new therapies in myelodysplastic syndromes

Affiliations

• ¹ University of North Carolina, Lineberger Comprehensive Cancer Center, Chapel Hill, NC. joshua_zeidner@med.unc.edu.
• ² Modus Outcomes, a division of THREAD, Lyon.
• ³ Millennium Pharmaceuticals, Inc. a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA.
• ⁴ AP-HP, Hôpital Saint Louis, Paris, France; University of Paris, and INSERM U944, Paris.
• ⁵ Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL.